• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

The Oncology Endgame: Assemble and Shine with AI and Precision Medicine, or Lose.

Wednesday, June 05, 2024
Breakout Session
Oncology
26B
Are you prepared for the oncology paradigm shift? The emergence of powerful precision and personalized medicine platforms is ushering in a renaissance in oncology drug development. Biopharma companies that are not aware of these enabling technologies, or do not have adequate strategies to integrate them in their workflow, risk being left behind. This panel, led by industry trailblazers, unlocks synergies in cutting-edge AI/ML, personalized medicine, and indispensable collaborations for winning oncology's endgame. Together, we will bring to light actionable strategies, avenues in making these accessible even to smaller biopharma companies, and the imperative for coming together to accelerate breakthroughs and blockbusters in oncology. Join this panel to arm yourself with the knowledge and connections to ensure that you're at the forefront of oncology's exhilarating evolution, not left in the shadows of outdated methodologies.
Moderator
Karim Budhwani, PhD, DLA
CEO-Scientist
CerFlux
Speakers
Tahera Kan, MS
Vice President, Head of Precision Medicine
Johnson & Johnson
Sandeep Menon, PhD
Chief Scientific Officer, AI Digital Sciences and SVP, Head of Early Clinical Development
Pfizer
Maggie Scully, PhD
Partnership Development Director
Frederick National Laboratory for Cancer Research
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS